These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19506976)

  • 1. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
    Huang J; Li BK; Chen GH; Li JQ; Zhang YQ; Li GH; Yuan YF
    J Gastrointest Surg; 2009 Sep; 13(9):1627-35. PubMed ID: 19506976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
    Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
    Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more.
    Hamaoka M; Kobayashi T; Ishiyama K; Ohira M; Tahara H; Kuroda S; Iwako H; Okimoto S; Honmyo N; Ohdan H
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):58-64. PubMed ID: 27860361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy.
    Hsu KF; Yu JC; Yang CW; Chen BC; Chen CJ; Chan DC; Fan HL; Chen TW; Shih YL; Hsieh TY; Hsieh CB
    Surg Oncol; 2018 Sep; 27(3):595-601. PubMed ID: 30217323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.
    Shi C; Zhao Q; Liao B; Dong Z; Wang C; Yang J; Shen W
    ANZ J Surg; 2019 Nov; 89(11):E482-E486. PubMed ID: 31618805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
    Li Q; Li H; Qin Y; Wang PP; Hao X
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?
    Khandoga A; Drefs M; Schoenberg M; Schiergens T; Frenes K; Op den Winkel M; Trumm C; Angele MK; Guba M; Werner J; Rentsch M
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1045-1053. PubMed ID: 28562395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of hepatectomy for elderly patients with hepatocellular carcinoma.
    Kishida N; Hibi T; Itano O; Okabayashi K; Shinoda M; Kitago M; Abe Y; Yagi H; Kitagawa Y
    Ann Surg Oncol; 2015 Sep; 22(9):3094-101. PubMed ID: 25582743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 18. Implication of microscopic and macroscopic vascular invasion for liver resection in patients with hepatocellular carcinoma.
    Faber W; Stockmann M; Kruschke JE; Denecke T; Bahra M; Seehofer D
    Dig Surg; 2014; 31(3):204-9. PubMed ID: 25196847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.